Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Post-Surgical Complications in Breast Cancer
NCT06087237Phase 2Completed
- Sponsor
- Mansoura University
- Start
- Oct 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of pentoxifylline (2 arms), sponsored by Mansoura University. Primary endpoint: Postoperative pain at 24 hours. Started Oct 2023; status: completed.
02
Drugs
pentoxifylline
Beyond the preview
Go deeper on NCT06087237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06087237.